-
1
-
-
36549030784
-
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
-
Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 2007; 450:566-569.
-
(2007)
Nature
, vol.450
, pp. 566-569
-
-
Collison, L.W.1
Workman, C.J.2
Kuo, T.T.3
Boyd, K.4
Wang, Y.5
Vignali, K.M.6
Cross, R.7
Sehy, D.8
Blumberg, R.S.9
Vignali, D.A.10
-
2
-
-
79959572627
-
Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance
-
Chaturvedi V, Collison LW, Guy CS, Workman CJ, Vignali DA. Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J Immunol. 2011; 186:6661-6666.
-
(2011)
J Immunol
, vol.186
, pp. 6661-6666
-
-
Chaturvedi, V.1
Collison, L.W.2
Guy, C.S.3
Workman, C.J.4
Vignali, D.A.5
-
3
-
-
75149158969
-
Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC
-
Seyerl M, Kirchberger S, Majdic O, Seipelt J, Jindra C, Schrauf C, Stockl J. Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC. Eur J Immunol. 2010; 40:321-329.
-
(2010)
Eur J Immunol
, vol.40
, pp. 321-329
-
-
Seyerl, M.1
Kirchberger, S.2
Majdic, O.3
Seipelt, J.4
Jindra, C.5
Schrauf, C.6
Stockl, J.7
-
4
-
-
79953030082
-
Detectable expression of IL-35 in CD4+ T cells from peripheral blood of chronic hepatitis B patients
-
Liu F, Tong F, He Y, Liu H. Detectable expression of IL-35 in CD4+ T cells from peripheral blood of chronic hepatitis B patients. Clin Immunol. 2011; 139:1-5.
-
(2011)
Clin Immunol
, vol.139
, pp. 1-5
-
-
Liu, F.1
Tong, F.2
He, Y.3
Liu, H.4
-
5
-
-
84897027520
-
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
-
Shen P, Roch T, Lampropoulou V, O'Connor RA, Stervbo U, Hilgenberg E, Ries S, Dang VD, Jaimes Y, Daridon C, Li R, Jouneau L, Boudinot P, et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature. 2014; 507:366-370.
-
(2014)
Nature
, vol.507
, pp. 366-370
-
-
Shen, P.1
Roch, T.2
Lampropoulou, V.3
O'Connor, R.A.4
Stervbo, U.5
Hilgenberg, E.6
Ries, S.7
Dang, V.D.8
Jaimes, Y.9
Daridon, C.10
Li, R.11
Jouneau, L.12
Boudinot, P.13
-
6
-
-
84902078796
-
Interleukin-35 induces regulatory B cells that suppress autoimmune disease
-
Wang RX, Yu CR, Dambuza IM, Mahdi RM, Dolinska MB, Sergeev YV, Wingfield PT, Kim SH, Egwuagu CE. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med. 2014; 20:633-641.
-
(2014)
Nat Med
, vol.20
, pp. 633-641
-
-
Wang, R.X.1
Yu, C.R.2
Dambuza, I.M.3
Mahdi, R.M.4
Dolinska, M.B.5
Sergeev, Y.V.6
Wingfield, P.T.7
Kim, S.H.8
Egwuagu, C.E.9
-
7
-
-
84919664607
-
Clinical implications of basic science discoveries: janus resurrected-two faces of B cell and plasma cell biology
-
Woodle ES, Rothstein DM. Clinical implications of basic science discoveries: janus resurrected-two faces of B cell and plasma cell biology. Am J Transplant. 2015; 15:39-43.
-
(2015)
Am J Transplant
, vol.15
, pp. 39-43
-
-
Woodle, E.S.1
Rothstein, D.M.2
-
8
-
-
78449296907
-
IL-35-mediated induction of a potent regulatory T cell population
-
Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, Finkelstein D, Forbes K, Workman CJ, Brown SA, Rehg JE, Jones ML, Ni HT, et al. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol. 2010; 11:1093-1101.
-
(2010)
Nat Immunol
, vol.11
, pp. 1093-1101
-
-
Collison, L.W.1
Chaturvedi, V.2
Henderson, A.L.3
Giacomin, P.R.4
Guy, C.5
Bankoti, J.6
Finkelstein, D.7
Forbes, K.8
Workman, C.J.9
Brown, S.A.10
Rehg, J.E.11
Jones, M.L.12
Ni, H.T.13
-
9
-
-
79960434330
-
Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35
-
Huang CH, Loo EX, Kuo IC, Soh GH, Goh DL, Lee BW, Chua KY. Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. J Immunol. 2011; 187:462-471.
-
(2011)
J Immunol
, vol.187
, pp. 462-471
-
-
Huang, C.H.1
Loo, E.X.2
Kuo, I.C.3
Soh, G.H.4
Goh, D.L.5
Lee, B.W.6
Chua, K.Y.7
-
10
-
-
84455199735
-
IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease
-
e201-205
-
Whitehead GS, Wilson RH, Nakano K, Burch LH, Nakano H, Cook DN. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol. 2012; 129:207-215 e201-205.
-
(2012)
J Allergy Clin Immunol
, vol.129
, pp. 207-215
-
-
Whitehead, G.S.1
Wilson, R.H.2
Nakano, K.3
Burch, L.H.4
Nakano, H.5
Cook, D.N.6
-
11
-
-
84925875466
-
IL-35: A potential therapeutic target for controlling hepatitis B virus infection
-
Xiang XG, Xie Q. IL-35: A potential therapeutic target for controlling hepatitis B virus infection. J Dig Dis. 2015; 16:1-6.
-
(2015)
J Dig Dis
, vol.16
, pp. 1-6
-
-
Xiang, X.G.1
Xie, Q.2
-
12
-
-
84956708941
-
Interleukin-35 is upregulated in response to influenza virus infection and secondary bacterial pneumonia
-
Chen Y, Wang CJ, Lin SH, Zhang M, Li SY, Xu F. Interleukin-35 is upregulated in response to influenza virus infection and secondary bacterial pneumonia. Cytokine. 2016; 81:23-27.
-
(2016)
Cytokine
, vol.81
, pp. 23-27
-
-
Chen, Y.1
Wang, C.J.2
Lin, S.H.3
Zhang, M.4
Li, S.Y.5
Xu, F.6
-
13
-
-
84902195117
-
Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice
-
Thiolat A, Denys A, Petit M, Biton J, Lemeiter D, Herve R, Lutomski D, Boissier MC, Bessis N. Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice. Cytokine. 2014; 69:87-93.
-
(2014)
Cytokine
, vol.69
, pp. 87-93
-
-
Thiolat, A.1
Denys, A.2
Petit, M.3
Biton, J.4
Lemeiter, D.5
Herve, R.6
Lutomski, D.7
Boissier, M.C.8
Bessis, N.9
-
14
-
-
84983196972
-
Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease
-
Tomcik M, Zerr P, Palumbo-Zerr K, Storkanova H, Hulejova H, Spiritovic M, Kodet O, Stork J, Becvar R, Vencovsky J, Pavelka K, Filkova M, Distler JH, et al. Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease. Rheumatology (Oxford). 2015.
-
(2015)
Rheumatology (Oxford)
-
-
Tomcik, M.1
Zerr, P.2
Palumbo-Zerr, K.3
Storkanova, H.4
Hulejova, H.5
Spiritovic, M.6
Kodet, O.7
Stork, J.8
Becvar, R.9
Vencovsky, J.10
Pavelka, K.11
Filkova, M.12
Distler, J.H.13
-
15
-
-
84938493774
-
Interleukin-35 administration counteracts established murine type 1 diabetes-possible involvement of regulatory T cells
-
Singh K, Kadesjo E, Lindroos J, Hjort M, Lundberg M, Espes D, Carlsson PO, Sandler S, Thorvaldson L. Interleukin-35 administration counteracts established murine type 1 diabetes-possible involvement of regulatory T cells. Sci Rep. 2015; 5:12633.
-
(2015)
Sci Rep
, vol.5
, pp. 12633
-
-
Singh, K.1
Kadesjo, E.2
Lindroos, J.3
Hjort, M.4
Lundberg, M.5
Espes, D.6
Carlsson, P.O.7
Sandler, S.8
Thorvaldson, L.9
-
16
-
-
36248970671
-
IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells
-
Niedbala W, Wei XQ, Cai B, Hueber AJ, Leung BP, McInnes IB, Liew FY. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol. 2007; 37:3021-3029.
-
(2007)
Eur J Immunol
, vol.37
, pp. 3021-3029
-
-
Niedbala, W.1
Wei, X.Q.2
Cai, B.3
Hueber, A.J.4
Leung, B.P.5
McInnes, I.B.6
Liew, F.Y.7
-
17
-
-
84973437066
-
IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects
-
Liu Y, Wu Y, Wang Y, Cai Y, Hu B, Bao G, Fang H, Zhao L, Ma S, Cheng Q, Song Y, Zhu Z, Chang H, et al. IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects. Leukemia. 2014.
-
(2014)
Leukemia
-
-
Liu, Y.1
Wu, Y.2
Wang, Y.3
Cai, Y.4
Hu, B.5
Bao, G.6
Fang, H.7
Zhao, L.8
Ma, S.9
Cheng, Q.10
Song, Y.11
Zhu, Z.12
Chang, H.13
-
18
-
-
84979883594
-
Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graftversus-host disease after allogeneic hematopoietic stem cell transplantation
-
Zhang X, Zhou Y, Xu L, Han W, Chen H, Chen Y, Fu H, Zhou S, Zhao J, Wang Q, Feng F, Zhu X, Liu K, et al. Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graftversus-host disease after allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2014.
-
(2014)
Ann Hematol
-
-
Zhang, X.1
Zhou, Y.2
Xu, L.3
Han, W.4
Chen, H.5
Chen, Y.6
Fu, H.7
Zhou, S.8
Zhao, J.9
Wang, Q.10
Feng, F.11
Zhu, X.12
Liu, K.13
-
19
-
-
80053474761
-
Identification of Epstein-Barr virusinduced gene 3 as a novel serum and tissue biomarker and a therapeutic target for lung cancer
-
Nishino R, Takano A, Oshita H, Ishikawa N, Akiyama H, Ito H, Nakayama H, Miyagi Y, Tsuchiya E, Kohno N, Nakamura Y, Daigo Y. Identification of Epstein-Barr virusinduced gene 3 as a novel serum and tissue biomarker and a therapeutic target for lung cancer. Clin Cancer Res. 2011; 17:6272-6286.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 6272-6286
-
-
Nishino, R.1
Takano, A.2
Oshita, H.3
Ishikawa, N.4
Akiyama, H.5
Ito, H.6
Nakayama, H.7
Miyagi, Y.8
Tsuchiya, E.9
Kohno, N.10
Nakamura, Y.11
Daigo, Y.12
-
20
-
-
84908390756
-
IL-35 promotes pancreas cancer growth through enhancement of proliferation and inhibition of apoptosis: evidence for a role as an autocrine growth factor
-
Nicholl MB, Ledgewood CL, Chen X, Bai Q, Qin C, Cook KM, Herrick EJ, Diaz-Arias A, Moore BJ, Fang Y. IL-35 promotes pancreas cancer growth through enhancement of proliferation and inhibition of apoptosis: evidence for a role as an autocrine growth factor. Cytokine. 2014; 70:126-133.
-
(2014)
Cytokine
, vol.70
, pp. 126-133
-
-
Nicholl, M.B.1
Ledgewood, C.L.2
Chen, X.3
Bai, Q.4
Qin, C.5
Cook, K.M.6
Herrick, E.J.7
Diaz-Arias, A.8
Moore, B.J.9
Fang, Y.10
-
21
-
-
84885362636
-
Assessing the role of IL-35 in colorectal cancer progression and prognosis
-
Zeng JC, Zhang Z, Li TY, Liang YF, Wang HM, Bao JJ, Zhang JA, Wang WD, Xiang WY, Kong B, Wang ZY, Wu BH, Chen XD, et al. Assessing the role of IL-35 in colorectal cancer progression and prognosis. Int J Clin Exp Pathol. 2013; 6:1806-1816.
-
(2013)
Int J Clin Exp Pathol
, vol.6
, pp. 1806-1816
-
-
Zeng, J.C.1
Zhang, Z.2
Li, T.Y.3
Liang, Y.F.4
Wang, H.M.5
Bao, J.J.6
Zhang, J.A.7
Wang, W.D.8
Xiang, W.Y.9
Kong, B.10
Wang, Z.Y.11
Wu, B.H.12
Chen, X.D.13
-
22
-
-
84929398541
-
Interleukin 35 is an independent prognostic factor and a therapeutic target for nasopharyngeal carcinoma
-
Zhang Y, Sun H, Wu H, Tan Q, Xiang K. Interleukin 35 is an independent prognostic factor and a therapeutic target for nasopharyngeal carcinoma. Contemp Oncol (Pozn). 2015; 19:120-124.
-
(2015)
Contemp Oncol (Pozn)
, vol.19
, pp. 120-124
-
-
Zhang, Y.1
Sun, H.2
Wu, H.3
Tan, Q.4
Xiang, K.5
-
23
-
-
84874275252
-
Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis
-
Wang Z, Liu JQ, Liu Z, Shen R, Zhang G, Xu J, Basu S, Feng Y, Bai XF. Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis. J Immunol. 2013; 190:2415-2423.
-
(2013)
J Immunol
, vol.190
, pp. 2415-2423
-
-
Wang, Z.1
Liu, J.Q.2
Liu, Z.3
Shen, R.4
Zhang, G.5
Xu, J.6
Basu, S.7
Feng, Y.8
Bai, X.F.9
-
24
-
-
84928594961
-
IL-35 over-expression is associated with genesis of gastric cancer
-
Fan YG, Zhai JM, Wang W, Feng B, Yao GL, An YH, Zeng C. IL-35 over-expression is associated with genesis of gastric cancer. Asian Pac J Cancer Prev. 2015; 16:2845-2849.
-
(2015)
Asian Pac J Cancer Prev
, vol.16
, pp. 2845-2849
-
-
Fan, Y.G.1
Zhai, J.M.2
Wang, W.3
Feng, B.4
Yao, G.L.5
An, Y.H.6
Zeng, C.7
-
25
-
-
84879925475
-
Epidemiology of hepatocellular carcinoma: consider the population
-
Mittal S, El-Serag HB. Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol. 2013; 47:S2-6.
-
(2013)
J Clin Gastroenterol
, vol.47
, pp. S2-S6
-
-
Mittal, S.1
El-Serag, H.B.2
-
26
-
-
84904651915
-
The pathogenesis of hepatocellular carcinoma
-
Kirstein MM, Vogel A. The pathogenesis of hepatocellular carcinoma. Dig Dis. 2014; 32:545-553.
-
(2014)
Dig Dis
, vol.32
, pp. 545-553
-
-
Kirstein, M.M.1
Vogel, A.2
-
27
-
-
84872407360
-
IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells
-
Long J, Zhang X, Wen M, Kong Q, Lv Z, An Y, Wei XQ. IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells. Biochem Biophys Res Commun. 2013; 430:364-369.
-
(2013)
Biochem Biophys Res Commun
, vol.430
, pp. 364-369
-
-
Long, J.1
Zhang, X.2
Wen, M.3
Kong, Q.4
Lv, Z.5
An, Y.6
Wei, X.Q.7
-
28
-
-
0036674501
-
Dissemination and growth of cancer cells in metastatic sites
-
Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002; 2:563-572.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 563-572
-
-
Chambers, A.F.1
Groom, A.C.2
MacDonald, I.C.3
-
29
-
-
22544461319
-
The "emigration, migration, and immigration"of prostate cancer
-
Pienta KJ, Loberg R. The "emigration, migration, and immigration"of prostate cancer. Clin Prostate Cancer. 2005; 4:24-30.
-
(2005)
Clin Prostate Cancer
, vol.4
, pp. 24-30
-
-
Pienta, K.J.1
Loberg, R.2
-
30
-
-
0141988569
-
The role of apoptosis in tumor progression and metastasis
-
Townson JL, Naumov GN, Chambers AF. The role of apoptosis in tumor progression and metastasis. Curr Mol Med. 2003; 3:631-642.
-
(2003)
Curr Mol Med
, vol.3
, pp. 631-642
-
-
Townson, J.L.1
Naumov, G.N.2
Chambers, A.F.3
-
31
-
-
84958107720
-
Interleukin-35 Limits Anti-Tumor Immunity
-
Turnis ME, Sawant DV, Szymczak-Workman AL, Andrews LP, Delgoffe GM, Yano H, Beres AJ, Vogel P, Workman CJ, Vignali DA. Interleukin-35 Limits Anti-Tumor Immunity. Immunity. 2016; 44:316-329.
-
(2016)
Immunity
, vol.44
, pp. 316-329
-
-
Turnis, M.E.1
Sawant, D.V.2
Szymczak-Workman, A.L.3
Andrews, L.P.4
Delgoffe, G.M.5
Yano, H.6
Beres, A.J.7
Vogel, P.8
Workman, C.J.9
Vignali, D.A.10
-
32
-
-
84857193362
-
The composition and signaling of the IL-35 receptor are unconventional
-
Collison LW, Delgoffe GM, Guy CS, Vignali KM, Chaturvedi V, Fairweather D, Satoskar AR, Garcia KC, Hunter CA, Drake CG, Murray PJ, Vignali DA. The composition and signaling of the IL-35 receptor are unconventional. Nat Immunol. 2012; 13:290-299.
-
(2012)
Nat Immunol
, vol.13
, pp. 290-299
-
-
Collison, L.W.1
Delgoffe, G.M.2
Guy, C.S.3
Vignali, K.M.4
Chaturvedi, V.5
Fairweather, D.6
Satoskar, A.R.7
Garcia, K.C.8
Hunter, C.A.9
Drake, C.G.10
Murray, P.J.11
Vignali, D.A.12
-
33
-
-
33749610184
-
P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma
-
Qian YB, Zhang JB, Wu WZ, Fang HB, Jia WD, Zhuang PY, Zhang BH, Pan Q, Xu Y, Wang L, Tang ZY, Sun HC. P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma. Cancer. 2006; 107:1562-1569.
-
(2006)
Cancer
, vol.107
, pp. 1562-1569
-
-
Qian, Y.B.1
Zhang, J.B.2
Wu, W.Z.3
Fang, H.B.4
Jia, W.D.5
Zhuang, P.Y.6
Zhang, B.H.7
Pan, Q.8
Xu, Y.9
Wang, L.10
Tang, Z.Y.11
Sun, H.C.12
|